Theorem Clinical Research

Sigma-Aldrich

Merck to acquire Sigma-Aldrich

Monday, September 22, 2014 02:31 PM

Merck has agreed to acquire Sigma-Aldrich, a St. Louis, Mo.-based life science and technology company, for $17 billion in an all-cash transaction.

More... »


Sigma-Aldrich, University of Michigan Medical School partner

Friday, September 19, 2014 12:45 PM

Sigma-Aldrich (SIAL), a St. Louis, Mo.-based life science and high technology company, has entered into a new gene editing partnership with the University of Michigan (U-M) Medical School's Vector Core. Sigma-Aldrich will provide the Vector Core with Sigma CRISPR technology, experimental design consultation and dedicated gene editing bioinformaticians.

More... »


SAFC to support next-gen NSAID product development

Monday, November 5, 2012 11:16 AM

Sigma-Aldrich’s custom manufacturing and services business unit, SAFC, has signed an agreement with South Korea-based CrystalGenomics, a clinical stage biopharmaceutical company, to support the development of active pharmaceutical ingredients (APIs) for next-generation non-steroidal anti-inflammatory drugs (NSAID).

More... »

Sigma-Aldrich acquires Research Organics

Wednesday, April 4, 2012 10:53 AM

Sigma-Aldrich, a life science and high technology company, has acquired all outstanding shares of Cleveland-based Research Organics, a supplier of high purity biochemicals.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 22

Roche/Genentech plans pilot trial to measure patientpreference for participating at home v. at study site

Bipartisan 21st Century Cures initiative prepares to draft legislation to accelerate biomedical R&D, lower cost

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs